Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal; ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Portugal.
Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal; ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Portugal.
J Pain. 2021 Oct;22(10):1134-1145. doi: 10.1016/j.jpain.2021.03.157. Epub 2021 May 1.
Chronic pain is a common condition among people with hemophilia (PWH), associated with joint deterioration due to repeated joint bleeds. This systematic review and meta-analysis aimed to determine the prevalence of chronic pain due to haemophilia and to analyze its interference in the lives of patients. A systematic search was performed in May and June 2019 and updated in February 2021, using PubMed, EMBASE, Web of Science and SciElo. The search included terms related to hemophilia, pain, pain prevalence and pain interference. Studies were included if they reported data referring to hemophilia-related chronic pain among adult males (age ≥18). From 3,258 identified studies, 11 met the inclusion criteria. Three studies used a proposed definition for hemophilia-related chronic pain and 8 used direct questions developed by the authors. For the global samples, prevalence ranged from 17% to 84%. The random-effects meta-analysis including all studies demonstrated a pooled prevalence of chronic pain of 46% (95% Confidence Interval, CI = 34%-58%). Subgroup analysis of samples including all disease severities or including only severe patients revealed a pooled prevalence of 48% (95% CI = 29%-67%) and 53% (95% CI = 38%-69%), respectively. High heterogeneity between studies was observed in all models. Information concerning chronic pain interference was retrieved from 1 study, reporting a mean interference of 3.7 (0-10 numerical rating scale from the Brief Pain Inventory). This systematic review revealed a wide prevalence range of hemophilia-related chronic pain across studies, varying methodologies and sample characteristics. Research in the hemophilia field should clearly distinguish between acute and chronic pain and provide complete characterization of study samples. PERSPECTIVE: Pain is a central issue in the lives of people with hemophilia, posing a significant challenge for healthcare providers. A clear picture of chronic pain due to hemophilia is precluded by high heterogeneity among studies and various definitions used to investigate its prevalence.
慢性疼痛是血友病患者(PWH)的常见病症,与因反复关节出血导致的关节恶化有关。本系统评价和荟萃分析旨在确定由血友病引起的慢性疼痛的患病率,并分析其对患者生活的干扰。系统检索于 2019 年 5 月至 6 月进行,并于 2021 年 2 月更新,使用了 PubMed、EMBASE、Web of Science 和 SciELO。检索词包括血友病、疼痛、疼痛患病率和疼痛干扰相关的术语。如果研究报告了成年男性(年龄≥18 岁)与血友病相关的慢性疼痛数据,则纳入研究。从 3258 项确定的研究中,有 11 项符合纳入标准。其中 3 项研究使用了血友病相关慢性疼痛的既定定义,8 项研究使用了作者自行开发的直接问题。对于全球样本,患病率范围为 17%至 84%。纳入所有研究的随机效应荟萃分析显示,慢性疼痛的总体患病率为 46%(95%置信区间,CI=34%-58%)。包括所有疾病严重程度样本或仅包括严重患者样本的亚组分析分别显示,慢性疼痛的患病率为 48%(95%CI=29%-67%)和 53%(95%CI=38%-69%)。在所有模型中,研究之间均存在高度异质性。从 1 项研究中检索到关于慢性疼痛干扰的信息,报告了Brief Pain Inventory 平均干扰值为 3.7(0-10 数字评分)。本系统评价显示,不同研究之间慢性疼痛的患病率差异很大,研究方法和样本特征各不相同。血友病领域的研究应明确区分急性和慢性疼痛,并对研究样本进行全面描述。观点:疼痛是血友病患者生活中的一个核心问题,给医疗保健提供者带来了重大挑战。由于研究之间存在高度异质性以及用于调查其患病率的各种定义,因此对血友病引起的慢性疼痛的情况尚不清楚。